INTEGRATION OF MOLECULAR DOCKING AND MACHINE LEARNING FOR DRUG REPURPOSING IN THE DISCOVERY OF SARS-COV-2 ANTIVIRAL AGENTS
SARS-CoV-2 has emerged as a global pandemic, claiming approximately 6 million lives annually by the year 2023. First identified in December 2019 in Wuhan, China, the rapid spread of this virus has rendered it perilous, prompting researchers to fervently seek antiviral remedies. Urgent steps are r...
Saved in:
Main Author: | Hidayat, Gabriel |
---|---|
Format: | Theses |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/79768 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Similar Items
-
Molecular Docking Studies for Protein-Targeted Drug Development in SARS-CoV-2
by: Ahmad Dzulfikri Nurhan, -, et al.
Published: (2022) -
Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations
by: Kunlakanya Jitobaom, et al.
Published: (2022) -
Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations
by: Jitobaom K.
Published: (2023) -
Drug repurposing of quinine as antiviral against dengue virus infection
by: Shilu Malakar, et al.
Published: (2019) -
Drug repurposing of quinine as antiviral against dengue virus infection
by: Malakar, S, et al.
Published: (2020)